UNSPSC 51373428: Chlorpheniramine/dihydrocodeine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373428 Chlorpheniramine/dihydrocodeine/phenylephrine/phenylpropanolamine is a Commodity code that in practice captures state and local procurement of pharmaceutical preparations and medical products, primarily through correctional health systems and public health agencies purchasing parenteral solutions, controlled-substance injectables, and opioid-response pharmaceuticals to support incarcerated populations and community health initiatives. The Washington State Department of Corrections solicitation (RFQQK13020, RFQ, due October 7, 2026) exemplifies the primary buying pattern: procurement of parenteral nutrition solutions (TPN and PPN), intravenous solutions, and other parenteral products including controlled substances for medically necessary healthcare delivery across multiple correctional facilities, with strict 24-hour delivery windows and the ability to adjust formulations based on patient lab results. State departments of corrections and county public health agencies dominate the issuing-body mix; the Washington solicitation encourages small business, minority-owned, women-owned, and veteran-owned participation at 25%, 10%, 6%, and 5% respectively and requires prime contractors to develop subcontractor inclusion plans emphasizing minority and women-owned firms where feasible.

Recent activity concentrates in Washington and Florida. The Washington State Department of Corrections is seeking multiple contractors (up to three per region) across eight facilities spanning West, Central, and East regions with a contract term running November 26, 2026 through June 30, 2030 and fixed pricing through the initial two-year period; contractors must meet Washington State business licensure, Washington State Patrol NCIC clearance, and specified insurance requirements including $1 million Commercial General Liability and $2 million Professional Liability per occurrence. Seminole County, Florida's solicitation (IFB60459723LAS, IFB, due July 26, 2023) procured 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year term with one-year renewal option, delivered quarterly to the Seminole County Community Health Building; the procurement included E-Verify compliance and potential FEMA funding with associated federal environmental compliance requirements. Parenteral product procurement under this code requires demonstrated experience in IV solution preparation, patient monitoring, and rapid fulfillment capabilities.